Dr Rosa Legood MSc DPhil
- 1st Floor, Room 134
- LSHTM
- 15-17 Tavistock Place
- London
- WC1H 9SH
- T: +44 (0)207 958 8256
- F: +44 207 927 2701
Rosa joined LSHTM as a lecturer in 2007. Her training is in health economics and public health. Previously she worked at Oxford in the Department of Public Health and York Health Economics Consortium. She has specific expertise in modelling the cost-effectiveness of screening technologies and vaccination options.
Affiliation
Teaching
Rosa is a tutor for the Public Health Masters. She is co-organiser for the introduction to health economics module and lecturer on the economic evaluation module. She is currently supervising one PhD student.
Research
Her main research interests relate to conducting economic evaluations in both devloped and developing country settings. Specific methodolgical interests include both the technical aspects of modelling complex diseases (such as including infectiousness, and robust validation). In addition, she is interested in the gap between the needs of policy makers and the presentation of cost-effectiveness information. Rosa is the modelling lead for the HARP project http://www.harp-fp7.org/ investigating the cost-effectiveness of HPV screening for HIV positive women. Other project work includes assessment of school bullying and diabetic retinopathy.
Research areas
- Decision analysis
- Economic evaluation
- Health technology assessment
- Modelling
- Vaccines
Disciplines
- Economics
- Epidemiology
Disease and Health Conditions
- Cancer
Countries
- Brazil
- Burkina Faso
- South Africa
-
Selected publications
-
Calibrating models in economic evaluation: a seven-step approach.
Vanni, T.; Karnon, J.; Madan, J.; White, R.G.; Edmunds, W.J.; Foss, A.M.; Legood, R.;
Pharmacoeconomics, 2011; 29(1):35-49
-
Cost-effectiveness of routine and low-cost CD4 T-cell count compared with WHO clinical staging of HIV to guide initiation of antiretroviral therapy in resource-limited settings
Athan, E.; O'Brien, D.P.; Legood, R.
AIDS, 2010; 24(12):1887-1895
-
From cost-effectiveness information to decision-making on liquid-based cytology: Mind the gap.
Legood, R.; Wolstenholme, J.; Gray, A.;
Health Policy, 2008; 89(2):193-200
-
Health related quality of life in survivors of pneumococcal meningitis.
Legood, R.; Coen, P.G.; Knox, K.; Viner, R.M.; El Bashir, H.; Christie, D.; Patel, B.C.; Booy, R.;
Acta Paediatr, 2008; 98(3):543-7
-
Eliciting expert opinion for economic models: an applied example
Leal, J.; Wordsworth, S.; Legood, R.; Blair, E.
Value Health, 2007; 10(3):195-203
-
Lifetime effects, costs, and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies
Legood, R.; Gray, A.; Wolstenholme, J.; Moss, S.
BMJ, 2006; 332(7533):79-85
-
Screening for cervical cancer in India: How much will it cost? A trial based analysis of the cost per case detected
Legood, R.; Gray, A.M.; Mahe, C.; Wolstenholme, J.; Jayant, K.; Nene, B.M.; Shastri, S.S.; Malvi, S.G.; Muwonge, R.; Budukh, A.M.; Sankaranarayanan, R.
International Journal of Cancer, 2005; 117(6):981-987
- → View all Dr Rosa Legood's publications
